Monoamine oxidase inhibitors, combined with thymoleptics: Are they really unusable for human beings?
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry; D001933:Brain Stem; D002090:Butyrophenones / Q000494:pharmacology; D003863:Depression / Q000188:drug therapy; D005453:Fluorescence; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007520:Isocarboxazid / Q000494:pharmacology; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D051381:Rats; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology
D002090:Butyrophenones; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D007520:Isocarboxazid; D014191:Tranylcypromine; D010624:Phenelzine; D007099:Imipramine; D009526:Nialamide